dc.contributor.author | Özakman, S. | |
dc.contributor.author | Gören, M.Z. | |
dc.contributor.author | Nurten, A. | |
dc.contributor.author | Tekin, N. | |
dc.contributor.author | Kalaycı, R. | |
dc.contributor.author | Enginar, N. | |
dc.date.accessioned | 2021-12-21T08:40:32Z | |
dc.date.available | 2021-12-21T08:40:32Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 281298 | |
dc.identifier.uri | https://doi.org/10.1007/s00210-020-02001-1 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1047 | |
dc.description.abstract | Protein kinase C inhibitor tamoxifen reduces symptoms of acute mania in bipolar patients and mania-like behaviors in animals. Memory impairment and altered levels of glutamate and glutamate/glutamine ratio have been reported in mania. Tamoxifen suppresses | |
dc.description.sponsorship | This work was supported by the Scientific Research Projects Coordination Unit of Istanbul University (project number 31202). Acknowledgments | |
dc.language.iso | English | |
dc.publisher | Springer Science and Business Media Deutschland GmbH | |
dc.title | Effects of tamoxifen and glutamate and glutamine levels in brain regions in repeated sleep deprivation–induced mania model in mice | |
dc.type | Article | |
dc.relation.journal | Naunyn-Schmiedeberg's Archives of Pharmacology | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 619 | |
dc.identifier.endpage | 629 | |
dc.identifier.volume | 394 | |
dc.identifier.doi | 10.1007/s00210-020-02001-1 | |
dc.relation.issue | 4 | |
dc.relation.volume | 394 | |